cached image

Joseph J. Schildkraut - Publications

Affiliations: 
Harvard Medical School, Boston, MA, United States 
Area:
Biological psychiatry, catecholamines
Website:
http://www.news.harvard.edu/gazette/2008/10.23/11-mm.html

82 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Mooney JJ, Samson JA, McHale NL, Pappalarado KM, Alpert JE, Schildkraut JJ. Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study. Journal of Psychiatric Research. 47: 706-11. PMID 23490066 DOI: 10.1016/J.Jpsychires.2013.02.005  0.328
2008 Mooney JJ, Samson JA, Hennen J, Pappalardo K, McHale N, Alpert J, Koutsos M, Schildkraut JJ. Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3). Journal of Psychiatric Research. 42: 605-11. PMID 17727882 DOI: 10.1016/J.Jpsychires.2007.07.009  0.354
2007 Schildkraut JJ, Cohn MB, Hawkins H. Then melancholy, now depression: a modern interpretation of Rembrandt's mental state in midlife. The Journal of Nervous and Mental Disease. 195: 3-9. PMID 17220733 DOI: 10.1097/01.Nmd.0000252263.74369.15  0.325
2004 Green AI, Chau DT, Keung WM, Dawson R, Mesholam RI, Schildkraut JJ. Clozapine reduces alcohol drinking in Syrian golden hamsters. Psychiatry Research. 128: 9-20. PMID 15450910 DOI: 10.1016/J.Psychres.2004.05.005  0.502
2004 Schildkraut JJ. Saint Jerome in a dark chamber: Rembrandt's metaphoric portrayal of the depressed mind. The American Journal of Psychiatry. 161: 26-7. PMID 14702245 DOI: 10.1176/Appi.Ajp.161.1.26  0.304
2003 Green A, Keung W, Chau D, Dawson R, Mesholam R, Schildkraut J. Clozapine limits alcohol drinking in hamsters: Implications for treatment of schizophrenia Schizophrenia Research. 60: 312. DOI: 10.1016/S0920-9964(03)80252-9  0.507
2002 Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Research. 111: 11-20. PMID 12140115 DOI: 10.1016/S0165-1781(02)00123-3  0.526
1999 Green AI, Zimmet SV, Strous RD, Schildkraut JJ. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harvard Review of Psychiatry. 6: 287-96. PMID 10370435 DOI: 10.3109/10673229909017206  0.543
1999 Posener JA, Schatzberg AF, Williams GH, Samson JA, McHale NL, Bessette MP, Schildkraut JJ. Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man. Biological Psychiatry. 45: 222-8. PMID 9951570 DOI: 10.1016/S0006-3223(97)00550-7  0.322
1998 Mooney JJ, Samson JA, McHale NL, Colodzin R, Alpert J, Koutsos M, Schildkraut JJ. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). Biological Psychiatry. 43: 574-83. PMID 9564442 DOI: 10.1016/S0006-3223(97)00327-2  0.307
1997 Posener JA, Schildkraut JJ, Williams GH, Schatzberg AF. Cortisol feedback effects on plasma corticotropin levels in healthy subjects. Psychoneuroendocrinology. 22: 169-76. PMID 9203227 DOI: 10.1016/S0306-4530(96)00046-7  0.328
1997 Stone WS, Seidman LJ, Kalinowski A, Shagrin B, Patel JK, Shafa R, Canuso C, Schildkraut JJ, Green AI. Effects of clozapine on cognitive functions in treatment-refractory schizophrenia Schizophrenia Research. 24: 188-189. DOI: 10.1016/S0920-9964(97)82539-X  0.502
1996 Vasile RG, Schwartz RB, Garada B, Holman BL, Alpert M, Davidson PB, Schildkraut JJ. Focal cerebral perfusion defects demonstrated by 99mTc-hexamethylpropyleneamine oxime SPECT in elderly depressed patients. Psychiatry Research. 67: 59-70. PMID 8797243 DOI: 10.1016/0925-4927(96)02689-3  0.341
1996 Posener JA, Schildkraut JJ, Samson JA, Schatzberg AF. Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology. 21: 33-8. PMID 8778902 DOI: 10.1016/0306-4530(95)00033-X  0.337
1995 Green AI, Schildkraut JJ. Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients. Harvard Review of Psychiatry. 3: 1-9. PMID 9384923 DOI: 10.3109/10673229509017159  0.547
1995 Samson JA, Gurrera RJ, Nisenson L, Schildkraut JJ. Platelet monoamine oxidase activity and deficit syndrome schizophrenia. Psychiatry Research. 56: 25-31. PMID 7792339 DOI: 10.1016/0165-1781(94)02555-W  0.321
1995 Schildkraut JJ, Kopin IJ, Schanberg SM, Durell J. Norepinephrine metabolism and psychoactive drugs in the endogenous depressions. 1968. Pharmacopsychiatry. 28: 24-37. PMID 7480108 DOI: 10.1055/S-2007-979616  0.573
1995 Schildkraut JJ, Hirshfeld AJ. Mind and Mood in Modern Art I: Miró and “Melancolie” Creativity Research Journal. 8: 139-156. DOI: 10.1207/S15326934Crj0802_3  0.3
1995 Posener JA, Schildkraut JJ, Williams GH, Gleason RE, Salomon MS, Schatzberg AF. Acute and delayed effects of adrenocorticotropic hormone on dopamine activity in man Depression. 2: 292-296. DOI: 10.1002/Depr.3050020603  0.354
1994 Schildkraut JJ, Hirshfeld AJ, Murphy JM. Mind and mood in modern art, II: Depressive disorders, spirituality, and early deaths in the abstract expressionist artists of the New York School. The American Journal of Psychiatry. 151: 482-8. PMID 8147444 DOI: 10.1176/Ajp.151.4.482  0.307
1994 Samson JA, Mirin SM, Griffin M, Borrelli D, Schildkraut JJ. Urinary MHPG and clinical symptoms in patients with unipolar depression. Psychiatry Research. 51: 157-65. PMID 8022950 DOI: 10.1016/0165-1781(94)90035-3  0.344
1994 Posener JA, Schildkraut JJ, Williams GH, Gleason RE, Salomon MS, Mecheri G, Schatzberg AF. Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man. Biological Psychiatry. 36: 616-21. PMID 7833428 DOI: 10.1016/0006-3223(94)90074-4  0.314
1993 Green AI, Alam MY, Sobieraj JT, Pappalardo KM, Waternaux C, Salzman C, Schatzberg AF, Schildkraut JJ. Clozapine response and plasma catecholamines and their metabolites. Psychiatry Research. 46: 139-49. PMID 8483973 DOI: 10.1016/0165-1781(93)90016-A  0.554
1993 Green AI, Alam MY, Boshes RA, Waternaux C, Pappalardo KM, Fitzgibbon ME, Tsuang MT, Schildkraut JJ. Haloperidol response and plasma catecholamines and their metabolites. Schizophrenia Research. 10: 33-7. PMID 8369230 DOI: 10.1016/0920-9964(93)90074-S  0.57
1993 Rothschild AJ, Samson JA, Bond TC, Luciana MM, Schildkraut JJ, Schatzberg AF. Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression. Biological Psychiatry. 34: 392-400. PMID 8218607 DOI: 10.1016/0006-3223(93)90184-F  0.348
1992 Samson JA, Mirin SM, Hauser ST, Fenton BT, Schildkraut JJ. Learned helplessness and urinary MHPG levels in unipolar depression. The American Journal of Psychiatry. 149: 806-9. PMID 1590498 DOI: 10.1176/Ajp.149.6.806  0.353
1992 Schatzberg AF, Bowden CL, Rosenbaum AH, Samson JA, Dessain E, Schildkraut JJ. EFFECTS OF FLUOXETINE AND DESIPRAMINE ON URINARY CATECHOLAMINE AND METABOLITE EXCRETION IN MAJOR DEPRESSION Clinical Neuropharmacology. 15: 415B. DOI: 10.1097/00002826-199202001-00807  0.351
1992 bowden c, schatzberg a, rosenbaum a, contreras s, schildkraut j, dessain e. Effects Of Fluoxetine & Desipramine On Platelet Imipramine Binding In Major Depression Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00637  0.323
1991 Mooney JJ, Schatzberg AF, Cole JO, Samson JA, Waternaux C, Gerson B, Pappalardo KM, Schildkraut JJ. Urinary 3-methoxy-4-hydroxyphenylglycol and the: Depression-type Score as Predictors of Differential Journal of Clinical Psychopharmacology. 11: 339-343. DOI: 10.1097/00004714-199112000-00002  0.332
1989 Schatzberg AF, Samson JA, Bloomingdale KL, Orsulak PJ, Gerson B, Kizuka PP, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Archives of General Psychiatry. 46: 260-8. PMID 2783211 DOI: 10.1001/Archpsyc.1989.01810030066009  0.358
1988 Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Salomon M, Lerbinger J, Pappalardo KM, Gerson B, Schildkraut JJ. Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biological Psychiatry. 23: 543-59. PMID 2833319 DOI: 10.1016/0006-3223(88)90002-9  0.333
1987 Schatzberg AF, Rothschild AJ, Langlais PJ, Lerbinger JE, Schildkraut JJ, Cole JO. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms. Psychiatry Research. 20: 155-64. PMID 3575560 DOI: 10.1016/0165-1781(87)90007-2  0.379
1986 Bloomingdale KL, Vasile RG, Gudeman JE, Gerson B, Schildkraut JJ. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression. Biological Psychiatry. 21: 390-3. PMID 3955113 DOI: 10.1016/0006-3223(86)90167-8  0.312
1985 Schatzberg AF, Rothschild AJ, Gerson B, Lerbinger JE, Schildkraut JJ. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity. The British Journal of Psychiatry : the Journal of Mental Science. 146: 633-7. PMID 4016477 DOI: 10.1192/Bjp.146.6.633  0.34
1985 Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, Harmatz JS, Tondorf R, Orsulak PJ, Schildkraut JJ. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology. 5: 10-6. PMID 3973067 DOI: 10.1097/00004714-198502000-00003  0.337
1985 Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Schildkraut JJ. Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: preliminary data. Journal of Psychiatric Research. 19: 65-75. PMID 2985777 DOI: 10.1016/0022-3956(85)90069-X  0.364
1984 Biederman J, Herzog DB, Rivinus TM, Ferber RA, Harper GP, Orsulak PJ, Harmatz JS, Schildkraut JJ. Urinary mhpg in anorexia nervosa patients with and without a concomitant major depressive disorder. Journal of Psychiatric Research. 18: 149-60. PMID 6747913 DOI: 10.1016/0022-3956(84)90006-2  0.364
1984 Biederman J, Rivinus TM, Herzog DB, Ferber RA, Harper GP, Orsulak PJ, Harmatz JS, Schildkraut JJ. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder. The American Journal of Psychiatry. 141: 1244-7. PMID 6486260 DOI: 10.1176/Ajp.141.10.1244  0.368
1984 Sheehan DV, Coleman JH, Greenblatt DJ, Jones KJ, Levine PH, Orsulak PJ, Peterson M, Schildkraut JJ, Uzogara E, Watkins D. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. Journal of Clinical Psychopharmacology. 4: 66-75. PMID 6142907 DOI: 10.1097/00004714-198404020-00002  0.323
1983 Schatzberg AF, Orsulak PJ, Rothschild AJ, Salomon MS, Lerbinger J, Kizuka PP, Cole JO, Schildkraut JJ. Platelet MAO activity and the dexamethasone suppression test in depressed patients. The American Journal of Psychiatry. 140: 1231-3. PMID 6614239 DOI: 10.1176/Ajp.140.9.1231  0.35
1981 Mooney JJ, Chao FC, Orsulak PJ, Adler SA, Schildkraut JJ. Platelet monoamine oxidase activity in psychiatric disorders: the application of a technique for the isolation of free platelet mitochondria from relatively small blood samples. Journal of Psychiatric Research. 16: 163-71. PMID 7346628 DOI: 10.1016/0022-3956(81)90002-9  0.504
1981 Cassens G, Kuruc A, Roffman M, Orsulak PJ, Schildkraut JJ. Alterations in brain norepinephrine metabolism and behavior induced by environmental stimuli previously paired with inescapable shock. Behavioural Brain Research. 2: 387-407. PMID 7225224 DOI: 10.1016/0166-4328(81)90020-6  0.317
1981 Schatzberg AF, Rosenbaum AH, Orsulak PJ, Rohde WA, Maruta T, Kruger ER, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline. Psychopharmacology. 75: 34-8. PMID 6795656 DOI: 10.1007/Bf00433498  0.356
1981 Cassens G, Actor C, Kling M, Schildkraut JJ. Amphetamine withdrawal: effects on threshold of intracranial reinforcement. Psychopharmacology. 73: 318-22. PMID 6789351 DOI: 10.1007/Bf00426458  0.311
1980 Cassens G, Roffman M, Kuruc A, Orsulak PJ, Schildkraut JJ. Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock. Science (New York, N.Y.). 209: 1138-40. PMID 7403874 DOI: 10.1126/Science.7403874  0.302
1980 Adler SA, Gottesman II, Orsulak PJ, Kizuka PP, Schildkraut JJ. Platelet MAO activity: relationships to clinical and psychometric variables. Schizophrenia Bulletin. 6: 226-31. PMID 7375854 DOI: 10.1093/Schbul/6.2.226  0.612
1980 Schildkraut JJ, Orsulak PJ, Schatzberg AF, Herzog JM. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders. Schizophrenia Bulletin. 6: 220-5. PMID 7375853 DOI: 10.1093/Schbul/6.2.220  0.36
1980 Reigle TG, Orsulak PJ, Avni J, Platz PA, Schildkraut JJ. The effects of tranylcypromine isomers on norepinephrine-H3 metabolism in rat brain. Psychopharmacology. 69: 193-9. PMID 6779313 DOI: 10.1007/Bf00427649  0.326
1979 Roffman M, Reigle T, Orsulak P, Cassens G, Schildkraut JJ. Further studies of the effects of morphine on the levels of MHPG-SO4 in rat brain. Neuropharmacology. 18: 483-7. PMID 460544 DOI: 10.1016/0028-3908(79)90074-1  0.327
1978 Schildkraut JJ, Orsulak PJ, LaBrie RA, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA. Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. Archives of General Psychiatry. 35: 1436-9. PMID 727879 DOI: 10.1001/Archpsyc.1978.01770360040004  0.341
1978 Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA, LaBrie RA. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Archives of General Psychiatry. 35: 1427-33. PMID 727878 DOI: 10.1001/Archpsyc.1978.01770360031003  0.372
1978 Roffman M, Cassens G, Schildkraut JJ. Effects of the d- and l-isomers of amphetamine on the levels of 3-methoxy-4-hydroxyphenylglycol sulfate in whole rat brain and rat brain regions. Biochemical Pharmacology. 27: 1774-7. PMID 708459 DOI: 10.1016/0006-2952(78)90556-7  0.302
1978 Meyer RE, Schildkraut JJ, Mirin SM, Orsulak PJ, Randall M, McDougle M, Platz PA, Grab E, Babor T. Opiates, catecholamines, behavior, and mood. Psychopharmacology. 56: 327-33. PMID 418442 DOI: 10.1007/Bf00432857  0.374
1976 Schildkraut JJ, Herzog JM, Orsulak PJ, Edelman SE, Shein HM, Frazier SH. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. The American Journal of Psychiatry. 133: 438-40. PMID 1267046 DOI: 10.1176/Ajp.133.4.438  0.3
1974 Schildkraut JJ. The effects of lithium on norepinephrine turnover and metabolism: basic and clinical studies. The Journal of Nervous and Mental Disease. 158: 348-60. PMID 4823935 DOI: 10.1097/00005053-197405000-00006  0.357
1974 Reigle TG, Avni J, Platz PA, Schildkraut JJ, Plotnikoff NP. Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone. Psychopharmacologia. 37: 1-6. PMID 4213267 DOI: 10.1007/Bf00426676  0.38
1973 Schildkraut JJ. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. The American Journal of Psychiatry. 130: 695-9. PMID 4701961 DOI: 10.1176/Ajp.130.6.695  0.373
1973 Schildkraut JJ, Keeler BA, Papousek M, Hartmann E. MHPG excretion in depressive disorders: relation to clinical subtypes and desynchronized sleep. Science (New York, N.Y.). 181: 762-4. PMID 4353428 DOI: 10.1126/Science.181.4101.762  0.351
1973 Roffler-Tarlov S, Schildkraut JJ, Draskoczy PR. Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain. Biochemical Pharmacology. 22: 2923-6. PMID 4148604 DOI: 10.1016/0006-2952(73)90161-5  0.304
1972 Schildkraut JJ, Draskoczy PR, Gershon ES, Reich P, Grab EL. Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline. Journal of Psychiatric Research. 9: 173-85. PMID 5083173 DOI: 10.1016/0022-3956(72)90019-2  0.421
1972 Schildkraut JJ, Hartmann E. Turnover and metabolism of norepinephrine in rat brain after 72 hours on a D-deprivation island. Psychopharmacologia. 27: 17-27. PMID 5081367 DOI: 10.1007/Bf00421953  0.36
1971 Schildkraut JJ, Draskoczy PR, Lo PS. Norepinephrine pools in rat brain: differences in turnover rates and pathways of metabolism. Science (New York, N.Y.). 172: 587-8. PMID 5555080 DOI: 10.1126/Science.172.3983.587  0.343
1971 Schildkraut JJ, Winokur A, Draskóczy PR, Hensle JH. Changes in norepinephrine turnover in rat brain during chronic administration of imipramine and protriptyline: a possible explanation for the delay in onset of clinical antidepressant effects. The American Journal of Psychiatry. 127: 1032-9. PMID 5541194 DOI: 10.1176/Ajp.127.8.1032  0.354
1971 Schildkraut JJ, Efron DH. The effects of delta-9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain. Psychopharmacologia. 20: 191-6. PMID 5090538 DOI: 10.1007/Bf00404373  0.374
1970 Schildkraut JJ, Winokur A, Applegate CW. Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine. Science (New York, N.Y.). 168: 867-9. PMID 5444064 DOI: 10.1126/Science.168.3933.867  0.346
1970 Greenspan K, Schildkraut JJ, Gordon EK, Baer L, Aronoff MS, Durell J. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. Journal of Psychiatric Research. 7: 171-83. PMID 5440858 DOI: 10.1016/0022-3956(70)90004-X  0.308
1970 Schildkraut JJ. Tranylcypromine: effects on norepinephrine metabolism in rat brain. The American Journal of Psychiatry. 126: 925-31. PMID 5409564 DOI: 10.1176/Ajp.126.7.925  0.406
1969 Schildkraut JJ, Schanberg SM, Breese GR, Kopin IJ. Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain. Biochemical Pharmacology. 18: 1971-8. PMID 5811629 DOI: 10.1016/0006-2952(69)90293-7  0.603
1969 Schildkraut JJ, Dodge GA, Logue MA. Effects of tricyclic antidepressants on the uptake and mabolism of intracisternally administered norepinephrine-H3 in rat brain. Journal of Psychiatric Research. 7: 29-34. PMID 5352848 DOI: 10.1016/0022-3956(69)90009-0  0.358
1969 Schildkraut JJ, Logue MA, Dodge GA. The effects of lthium salts on the turnover and metabolism of norepinephrine in rat brain. Psychopharmacologia. 14: 135-41. PMID 5350622 DOI: 10.1007/Bf00403686  0.359
1969 Greenspan K, Schildkraut JJ, Gordon EK, Levy B, Durell J. Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients. Archives of General Psychiatry. 21: 710-6. PMID 4901154 DOI: 10.1001/Archpsyc.1969.01740240070009  0.389
1969 Schildkraut JJ, Schanberg SM, Kopin IJ, Durell J. Affective disorders and norepinephrine pharmacology. International Psychiatry Clinics. 6: 83-141. PMID 4897536  0.487
1968 Schanberg SM, Schildkraut JJ, KrÄ­vánek J, Kopin IJ. Effect of cortical spreading depression on norepinephrine-H3 metabolism in brain stem. Experientia. 24: 909-10. PMID 5709032 DOI: 10.1007/Bf02138647  0.587
1968 Schanberg SM, Schildkraut JJ, Breese GR, Kopin IJ. Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochemical Pharmacology. 17: 247-54. PMID 5647052 DOI: 10.1016/0006-2952(68)90330-4  0.588
1967 Schanberg SM, Schildkraut JJ, Kopin IJ. The effects of pentobarbital on the fate of intracisternally administered norepinephrine-H3. The Journal of Pharmacology and Experimental Therapeutics. 157: 311-8. PMID 6039823  0.499
1967 Schanberg SM, Schildkraut JJ, Kopin IJ. The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochemical Pharmacology. 16: 393-9. PMID 6029920 DOI: 10.1016/0006-2952(67)90040-8  0.594
1967 Schildkraut JJ, Kety SS. Biogenic amines and emotion. Science (New York, N.Y.). 156: 21-37. PMID 5335690 DOI: 10.1126/Science.156.3771.21  0.579
1967 Schildkraut JJ, Schanberg SM, Breese GR, Kopin IJ. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. The American Journal of Psychiatry. 124: 600-8. PMID 4383104 DOI: 10.1176/Ajp.124.5.600  0.601
1966 Schildkraut JJ, Schanberg SM, Kopin IJ. The effects of lithium ion on H3-norepinephrine metabolism in brain. Life Sciences. 5: 1479-83. PMID 5969204 DOI: 10.1016/0024-3205(66)90221-9  0.519
1966 Schildkraut JJ, Green R, Gordon EK, Durell J. Normetanephrine excretion and affective state in depressed patients treated with imipramine. The American Journal of Psychiatry. 123: 690-700. PMID 5333088 DOI: 10.1176/Ajp.123.6.690  0.374
1964 SCHILDKRAUT JJ, KLERMAN GL, HAMMOND R, FRIEND DG. EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN DEPRESSED PATIENTS TREATED WITH ANTIDEPRESSANT DRUGS. Journal of Psychiatric Research. 2: 257-66. PMID 14271965 DOI: 10.1016/0022-3956(64)90012-3  0.365
1963 KLERMAN GL, SCHILDKRAUT JJ, HASENBUSH LL, GREENBLATT M, FRIEND DG. CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION. Journal of Psychiatric Research. 1: 289-97. PMID 14101009 DOI: 10.1016/0022-3956(63)90004-9  0.38
Show low-probability matches.